-
A Giant Step for Gene Therapy
St. Jude researchers offer proof that gene therapy can reduce the symptoms of hemophilia B.
-
Flu Fighters: How the Immune System Protects Infants from Influenza
St. Jude investigators discover how guardian T cells help combat influenza in infants and young children.
-
Gene Therapy for SCID: Thinking Outside the Bubble
Gene therapy offers hope for children born with a rare immune disease called severe combined immunodeficiency (SCID).
-
HPV: Prevention is Key
The new St. Jude HPV Cancer Prevention Program seeks to increase HPV vaccination rates to help reduce the number of deaths from six types of cancer.
-
Snip of DNA Spells Hope
St. Jude scientists use gene editing in quest to help children with sickle cell disease.
-
Something to Dance About: A Gentler Approach to Transplants
Using a gentler chemotherapy and radiation conditioning regimen, the Sickle Cell Disease Hematopoietic Cell Transplantation (SCDHCT) study aims to cure children with severe sickle cell disease and reduce side effects and subsequent health issues.
-
St. Jude Tells Malaria to Buzz Off
Scientists and clinicians team up to create a potential malaria drug that could save untold lives worldwide.
-
Thwarting the Threat
St. Jude scientists uncover secrets of bacteria that can be deadly to children with sickle cell disease.
-
When Genes Point to the Right Medicine
Researchers ensure that codeine is given only to children whose genes indicate it’s safe and effective.
-
Young Readers are STARRs
The STARR program provides academic assistance for children with sickle cell disease and hemophilia.
